FDG PET/CT in Breast Cancer Bone Mets
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bone Metastases
- Estrogen Receptor Positive Breast Cancer
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
This is an observational study as all patients will receive the same research diagnostic test, an FDG PET/CT study performed at 4 weeks after starting new hormone treatment.
This is an observational study as all patients will receive the same research diagnostic test, an FDG PET/CT study performed at 4 weeks after starting new hormone treatment.
Tracking Information
- NCT #
- NCT01996046
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: David Mankoff, MD, PhD University of Pennsylvania
Get Well Soon